Rockwell exec exercises options, sells 17,407 shares

Rockwell Automation senior vice president and chief revenue officer Scott Genereux reported option exercises and share sales in company stock.

Rhea-AI Filing Summary

Rockwell Automation senior vice president and chief revenue officer Scott Genereux reported option exercises and share sales in company stock. On February 25, 2026, he exercised employee stock options to acquire 6,844 common shares at $350.76 per share and 9,363 shares at $259.81 per share through derivative conversions. The filing also shows open-market sales totaling 17,407 common shares at weighted average prices ranging from about $401.67 to $409.37, executed under a pre-arranged Rule 10b5-1 trading plan entered into on November 26, 2025. After these transactions, his directly held common stock position was 3,314 shares.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 12 txns

Insider GENEREUX SCOTT

Role Sr.VP, Chief Revenue Officer

Sold 17,407 shs ($7.04M)

Approx. gross sale proceeds $7.04M

Approx. exercise cost $4.83M

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	6,844	$0.00	$0.00
Exercise	Employee Stock Option (Right to Buy)	9,363	$0.00	$0.00
Exercise	Common Stock	6,844	$350.76	$2.40M
Exercise	Common Stock	9,363	$259.81	$2.43M
Sale	Common Stock	2,942	$402.1566	$1.18M
Sale	Common Stock	2,584	$403.1022	$1.04M
Sale	Common Stock	4,861	$404.2438	$1.97M
Sale	Common Stock	3,899	$405.474	$1.58M
Sale	Common Stock	1,381	$406.422	$561K
Sale	Common Stock	460	$407.0437	$187K
Sale	Common Stock	80	$408.00	$33K
Sale	Common Stock	1,200	$409.37	$491K

Holdings After Transaction: Employee Stock Option (Right to Buy) — 300 contracts (Direct); Common Stock — 3,314 shares (Direct)

Footnotes (9)

1. F1. Shares exercised and sold pursuant to Rule 10b5-1 plan entered into on 11/26/2025.
2. F2. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $401.6650 to $402.60. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
3. F3. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $402.70 to $403.6850. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
4. F4. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $403.7750 to $404.77. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
5. F5. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $404.8250 to $405.7550. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
6. F6. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $405.86 to $406.84. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
7. F7. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $406.8650 to $407.66. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.
8. F8. Sale of shares pursuant to Rule 10b5-1 plan entered into on 11/26/2025.
9. F9. The option vests in three substantially equal annual installments beginning on the date exercisable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Scott Genereux report in Rockwell Automation (ROK)?

Scott Genereux, Rockwell Automation’s senior vice president and chief revenue officer, reported option exercises and sales on February 25, 2026. He exercised options into common stock and sold 17,407 shares in multiple open-market trades under a pre-established Rule 10b5-1 trading plan.

How many Rockwell Automation (ROK) shares did Scott Genereux sell?

Scott Genereux sold 17,407 Rockwell Automation common shares in several open-market transactions. The reported weighted average sale prices ranged from about $401.67 to $409.37 per share, with prices detailed in separate trade buckets disclosed in the Form 4 filing footnotes.

Did Scott Genereux acquire Rockwell Automation (ROK) shares through option exercises?

Yes. Scott Genereux exercised employee stock options to acquire 6,844 Rockwell Automation shares at $350.76 per share and 9,363 shares at $259.81 per share. These derivative exercises converted options into directly held common stock on February 25, 2026.

Were Scott Genereux’s Rockwell Automation (ROK) share sales under a Rule 10b5-1 plan?

Yes. The Form 4 footnotes state the exercised and sold shares were transacted under a Rule 10b5-1 trading plan entered into on November 26, 2025. Such plans pre-schedule trades, helping separate them from day-to-day discretionary trading decisions.

How many Rockwell Automation (ROK) shares does Scott Genereux hold after these transactions?

Following the reported transactions, Scott Genereux directly held 3,314 Rockwell Automation common shares. This ending balance reflects his option exercises into common stock and subsequent open-market sales recorded on February 25, 2026 in the Form 4 filing.

What prices were received for Scott Genereux’s Rockwell Automation (ROK) share sales?

The filing reports weighted average sale prices between about $401.67 and $409.37 per share across several trades. Footnotes explain shares were sold in multiple transactions within these ranges and that detailed price breakdowns are available upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 04:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GENEREUX SCOTT

(Last) (First) (Middle)

1201 SOUTH SECOND STREET

(Street)

MILWAUKEE WI 53204

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ROCKWELL AUTOMATION, INC [ ROK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr.VP, Chief Revenue Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/25/2026		M		6,844	A	$350.76	11,358	D
Common Stock	02/25/2026		M		9,363	A	$259.81	20,721	D
Common Stock	02/25/2026		S(1)		2,942	D	$402.1566(2)	17,779	D
Common Stock	02/25/2026		S(1)		2,584	D	$403.1022(3)	15,195	D
Common Stock	02/25/2026		S(1)		4,861	D	$404.2438(4)	10,334	D
Common Stock	02/25/2026		S(1)		3,899	D	$405.474(5)	6,435	D
Common Stock	02/25/2026		S(1)		1,381	D	$406.422(6)	5,054	D
Common Stock	02/25/2026		S(1)		460	D	$407.0437(7)	4,594	D
Common Stock	02/25/2026		S(1)		80	D	$408	4,514	D
Common Stock	02/25/2026		S(8)		1,200	D	$409.37	3,314	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$350.76	02/25/2026		M			6,844	12/07/2022(9)	12/07/2031	Common Stock	6,844	$0	0	D
Employee Stock Option (Right to Buy)	$259.81	02/25/2026		M			9,363	12/09/2023(9)	12/09/2032	Common Stock	9,363	$0	300	D

Explanation of Responses:

1. Shares exercised and sold pursuant to Rule 10b5-1 plan entered into on 11/26/2025.

2. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $401.6650 to $402.60. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.

3. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $402.70 to $403.6850. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.

4. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $403.7750 to $404.77. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.

5. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $404.8250 to $405.7550. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.

6. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $405.86 to $406.84. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.

7. Price reported in column 4 is a weighted average price. Shares sold at prices ranging from $406.8650 to $407.66. The reporting person undertakes to provide to the Company, any shareowners of the Company and the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price.

8. Sale of shares pursuant to Rule 10b5-1 plan entered into on 11/26/2025.

9. The option vests in three substantially equal annual installments beginning on the date exercisable.

Remarks:

	Danielle White, Attorney-in-fact for Scott Genereux	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.